Industry Growth Insights published a new data on “Non-opioid Analgesic Patch Market”. The research report is titled “Non-opioid Analgesic Patch Market research by Types (Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, Others), By Applications (Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores), By Players/Companies GlaxoSmithKline Plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd., Mylan N.V., Hisamitsu Pharmaceutical Co.,Inc, Acorda Therapeutics, Inc, Endo International plc, Allergan, Teh Seng Pharmaceutical Mfg, IBSA Institut Biochimque SA”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-opioid Analgesic Patch Market Research Report
By Type
Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, Others
By Application
Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores
By Companies
GlaxoSmithKline Plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd., Mylan N.V., Hisamitsu Pharmaceutical Co.,Inc, Acorda Therapeutics, Inc, Endo International plc, Allergan, Teh Seng Pharmaceutical Mfg, IBSA Institut Biochimque SA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Non-opioid Analgesic Patch Market Report Segments:
The global Non-opioid Analgesic Patch market is segmented on the basis of:
Types
Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Online Pharmacies, Independent Pharmacies & Drug Stores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline Plc
- Pfizer, Inc.
- Teikoku Seiyaku Co., Ltd.
- Mylan N.V.
- Hisamitsu Pharmaceutical Co.,Inc
- Acorda Therapeutics, Inc
- Endo International plc
- Allergan
- Teh Seng Pharmaceutical Mfg
- IBSA Institut Biochimque SA
Highlights of The Non-opioid Analgesic Patch Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lidocaine Patches
- Diclofenac Patches
- Methyl Salicylate Patches
- Capsaicin Patches
- Ketoprofen Patches
- Others
- By Application:
- Hospital Pharmacies
- Online Pharmacies
- Independent Pharmacies & Drug Stores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-opioid Analgesic Patch Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-opioid analgesic patches are a type of medication that provide relief from pain without the side effects of opioids. They work by releasing a numbing agent into the skin, which reduces pain sensations.
Some of the major players in the non-opioid analgesic patch market are GlaxoSmithKline Plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd., Mylan N.V., Hisamitsu Pharmaceutical Co.,Inc, Acorda Therapeutics, Inc, Endo International plc, Allergan, Teh Seng Pharmaceutical Mfg, IBSA Institut Biochimque SA.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Non-opioid Analgesic Patch Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Non-opioid Analgesic Patch Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Non-opioid Analgesic Patch Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Non-opioid Analgesic Patch Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Non-opioid Analgesic Patch Market Size & Forecast, 2018-2028
4.5.1 Non-opioid Analgesic Patch Market Size and Y-o-Y Growth
4.5.2 Non-opioid Analgesic Patch Market Absolute $ Opportunity
Chapter 5 Global Non-opioid Analgesic Patch Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Non-opioid Analgesic Patch Market Size Forecast by Type
5.2.1 Lidocaine Patches
5.2.2 Diclofenac Patches
5.2.3 Methyl Salicylate Patches
5.2.4 Capsaicin Patches
5.2.5 Ketoprofen Patches
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Non-opioid Analgesic Patch Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Non-opioid Analgesic Patch Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Online Pharmacies
6.2.3 Independent Pharmacies & Drug Stores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Non-opioid Analgesic Patch Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Non-opioid Analgesic Patch Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Non-opioid Analgesic Patch Analysis and Forecast
9.1 Introduction
9.2 North America Non-opioid Analgesic Patch Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Non-opioid Analgesic Patch Market Size Forecast by Type
9.6.1 Lidocaine Patches
9.6.2 Diclofenac Patches
9.6.3 Methyl Salicylate Patches
9.6.4 Capsaicin Patches
9.6.5 Ketoprofen Patches
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Non-opioid Analgesic Patch Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Online Pharmacies
9.10.3 Independent Pharmacies & Drug Stores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Non-opioid Analgesic Patch Analysis and Forecast
10.1 Introduction
10.2 Europe Non-opioid Analgesic Patch Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Non-opioid Analgesic Patch Market Size Forecast by Type
10.6.1 Lidocaine Patches
10.6.2 Diclofenac Patches
10.6.3 Methyl Salicylate Patches
10.6.4 Capsaicin Patches
10.6.5 Ketoprofen Patches
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Non-opioid Analgesic Patch Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Online Pharmacies
10.10.3 Independent Pharmacies & Drug Stores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Non-opioid Analgesic Patch Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Non-opioid Analgesic Patch Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Non-opioid Analgesic Patch Market Size Forecast by Type
11.6.1 Lidocaine Patches
11.6.2 Diclofenac Patches
11.6.3 Methyl Salicylate Patches
11.6.4 Capsaicin Patches
11.6.5 Ketoprofen Patches
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Non-opioid Analgesic Patch Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Online Pharmacies
11.10.3 Independent Pharmacies & Drug Stores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Non-opioid Analgesic Patch Analysis and Forecast
12.1 Introduction
12.2 Latin America Non-opioid Analgesic Patch Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Non-opioid Analgesic Patch Market Size Forecast by Type
12.6.1 Lidocaine Patches
12.6.2 Diclofenac Patches
12.6.3 Methyl Salicylate Patches
12.6.4 Capsaicin Patches
12.6.5 Ketoprofen Patches
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Non-opioid Analgesic Patch Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Online Pharmacies
12.10.3 Independent Pharmacies & Drug Stores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Non-opioid Analgesic Patch Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Non-opioid Analgesic Patch Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Non-opioid Analgesic Patch Market Size Forecast by Type
13.6.1 Lidocaine Patches
13.6.2 Diclofenac Patches
13.6.3 Methyl Salicylate Patches
13.6.4 Capsaicin Patches
13.6.5 Ketoprofen Patches
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Non-opioid Analgesic Patch Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Online Pharmacies
13.10.3 Independent Pharmacies & Drug Stores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Non-opioid Analgesic Patch Market: Competitive Dashboard
14.2 Global Non-opioid Analgesic Patch Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline Plc
14.3.2 Pfizer, Inc.
14.3.3 Teikoku Seiyaku Co., Ltd.
14.3.4 Mylan N.V.
14.3.5 Hisamitsu Pharmaceutical Co.,Inc
14.3.6 Acorda Therapeutics, Inc
14.3.7 Endo International plc
14.3.8 Allergan
14.3.9 Teh Seng Pharmaceutical Mfg
14.3.10 IBSA Institut Biochimque SA
